Contemporary OB/GYN®

The @ACPIMPhysicians says physicians should not be called “providers,” citing ethics, professionalism, and the patient–physician relationship. Do you agree?

A discussion of the recently updated HRSA guidelines on cervical cancer guidelines with Sangini Sheth, MD, MPH, Associate professor, Obstetrics, Gynecology; Division director, Obstetric, Gynecologic specialties; vice chair, Collaborative Excellence, Yale School of Medicine. Below, Sheth explains the awareness of the at-home self-collection. For more on the updated guidance and for our full interview with Sheth, click here: contemporaryobgyn.net/view/sangini-s…

Case report breakdown of shock wave therapy for chronic postpartum pain: Sarina Hangling, research coordinator for Rachel Rubin, MD, and a student at the University of Maryland School of Medicine, highlights a case report involving the use of low-intensity shock wave therapy for a patient with more than 2 decades of episiotomy scar pain and pelvic floor dysfunction. Watch the full discussion: hubs.ly/Q047LbRL0

In this clip, Xiteng Yan, MD, of the Icahn School of Medicine at Mount Sinai, discusses a study evaluating the incidence of uterine windows in patients undergoing C-sections. The study found that having 3 or more prior cesareans was independently associated with uterine windows (aOR, 3.39), and a history of prior window or rupture carried an even higher risk (aOR, 5.38). Watch our full discussion of this topic with Yan, here: hubs.li/Q047Ct-j0

Prescribing of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in the perinatal period increased more than thirtyfold between 2019 and 2024, according to findings from a large retrospective cohort study using a national electronic health records database—a trend investigators say underscores an urgent need for safety data in pregnant and postpartum populations. #GLP1 #GLP Kevin Young Xu, MD, PhD, of WashU School of Public Health, comments below. Click here for the full interview: hubs.li/Q047cQrM0

Today, Merck annouced it plans to present new, long-term efficacy data for a pair of #HPV vaccines, GARDASIL 9 and GARDASIL, at the upcoming EUROGIN Conference in Vienna. View the abstracts to be presented as well as additional information to expect from the pharmaceutical manufacturer, here: hubs.li/Q0478GQL0

In our latest video interview, Adnan Qureshi, MD, Professor of Neurology, University of Missouri-Columbia, and founder of Zeenat Qureshi Stroke Institutes, explains the increased risk of recurring stroke during #pregnancy. Watch the full interview and learn how women with stroke history face significantly increased risks during pregnancy, as well as the postpartum period. Watch here: hubs.li/Q046XlCF0

Welcome to a new week! We've got you covered on anything you may have missed from Contemporary OB/GYN last week, with our Weekly Review article below. From FAQs on the #ASCO guideline on #fertility preservation to endometrial stromal sarcoma analysis, view our top headlines from last week all in one place. Read our weekly review here: hubs.li/Q046W9Qs0

In our Sunday Spotlight video of the week: Sara Perelmuter of the Sexual Medicine Research Team, comments on including routine screening for symptoms of Genitourinary Syndrome of Lactation (GSL). The conversation with Contemporary OB/GYN follows research presented at the International Society for the Study of Womens Sexual Health (ISSWSH) Annual Meeting this year. WATCH: hubs.li/Q046NPWs0

In our Article of the Week, we highlight the announcement FLO Living made this week from a 3-month study, which demonstrated that the Cycle Syncing Method led to reductions in #PMS symptom burden and severity within 2 months. Specifically, 92% of participants reported reductions in the number and intensity of PMS symptoms within 60 days, with some improvements occurring as early as 30 days. Founder Alisa Vitti comments on the study results below. READ: hubs.li/Q046NK2_0

A recent longitudinal study published in JAMA Cardiology found that third-trimester levels of sFlt-1 and hs-cTnI were independently associated with higher long-term CVD risk, meaning #pregnancy represented a unique opportunity for CVD risk assessment. The authors concluded, "Pending further validation, pregnancy-derived risk indicators, including circulating biomarkers and clinical profiles, could inform earlier and more targeted preventive strategies across the life course of women." More on the data: hubs.li/Q046D5lT0

Learn key insights on screening & diagnosing postpartum depression (PPD) in the on-demand sponsored series Expert Insights on PPD. Hear experts discuss PPD collaborative care & listen to a mock patient-physician discussion. Watch now: bit.ly/3JvExPo #PPD #OBGYN

Sara Perelmuter of the Sexual Medicine Research Team, comments on including routine screening for symptoms of Genitourinary Syndrome of Lactation (GSL). The conversation with Contemporary OB/GYN follows research presented at the International Society for the Study of Womens Sexual Health (@ISSWSH) Annual Meeting this year. Watch our full interview with Perelmuter and learn more about GSL here: hubs.li/Q046MZqv0

Alessandro Santin, MD, of Yale School of Medicine, explains the potential for mutational analysis of endometrial stromal sarcoma, in an effort to use already #FDA-approved therapies for targeted treatment of this aggressive #cancer. Full video: hubs.li/Q046BWr50

ICYMI: We spoke with Raquel Dardik, MD, chief medical officer at Ultrasound AI, about the recent #FDA clearance of the Delivery Date AI technology, which analyzes #ultrasound images to predict a delivery date. #Pregnancy #deliverydate Watch the full interview: hubs.li/Q046CkQB0

Thank you, Sara Perelmuter (@sara_perelmuter) of the Sexual Medicine Research Team (@sexmedresearch), for speaking with us about Genitourinary Syndrome of Lactation. From defining the terminology to addressing care gaps to the prevalence of symptoms, Perelmuter describes the abstract presented at the International Society for the Study of Women's Sexual Health (@ISSWSH) Annual Meeting this year, more at the link below. #ISSWSH WATCH: contemporaryobgyn.net/view/sara-pere…

In this clip, following a case study presented at the International Society for the Study of Womens Sexual Health (ISSWSH) 2026, Julia Ordway, a third -year medical student at Tulane University School of Medicine, details the key takeaways for using safe and guided #hormone supplementation in postmenopausal #women. Click here for the full discussion and to learn more: hubs.li/Q0463Hkv0

Elizabeth A. Stewart, MD, FACOG, of @MayoClinic, joins us once again to talk about how attitudes on always using #hysterectomy for treating uterine fibroids are slowly changing. MORE: contemporaryobgyn.net/view/equity-in…

Welcome to a new week! We've got you covered on anything you may have missed from Contemporary OB/GYN last week, with our Weekly Review article below. From new data on a rare endometrial #cancer to the latest episode of our childhood #immunization panel, view our top headlines from last week all in one place. Read our weekly review here: hubs.li/Q0461z3F0

Sunday Spotlight: This week, we spoke with Kevin Benson, MD, of Sanford Health, and investigator of the TITAN 2 study, about new data for the Altaviva (Medtronic) system for urgency #urinary incontinence. The data were presented at #SUFU2026. For more, see the links below. Watch the interview below and view full, new, Altaviva safety, efficacy, and quality of life data here: hubs.li/Q045X_pt0

Today we celebrate the women who are advancing care, leading research, and advocating for better health outcomes for patients everywhere. On #InternationalWomensDay, Contemporary OB/GYN recognizes the physicians, researchers, and health care professionals who are shaping the future of women’s health through innovation, dedication, and compassionate care. Thank you for the impact you make every day—in the clinic, in research, and in the lives of your patients. 💜 #WomensHealth #OBGYN #IWD2026 #WomenInMedicine